Sector revisions Northwest Biotherapeutics, Inc. Börse Stuttgart

Stocks

Market Closed - Börse Stuttgart 15:56:03 2026-09-29 EDT			5-day change	1st Jan Change
0.1310 ^EUR	0.00%		-9.66%	-36.41%

08-14	Northwest Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-06	Northwest Biotherapeutics and Saudi Pharmaceutical Industries and Medical Appliance Company Enter Memorandum of Understanding for Collaboration	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Visibility	Nbr of analysts
WUXI APPTEC CO., LTD.		18
ARGENX SE		15
WUXI BIOLOGICS (CAYMAN) INC.		24
INSMED INCORPORATED		23
BIONTECH SE		20
GENMAB A/S		15
PHARMAESSENTIA CORPORATION		8
EXELIXIS, INC.		16
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.		19
SUMMIT THERAPEUTICS INC.		13
MADRIGAL PHARMACEUTICALS, INC.		18
AKESO, INC.		21
ARROWHEAD PHARMACEUTICALS, INC.		13
CYTOKINETICS, INCORPORATED		20
IMMUNITYBIO, INC.		4
VAXCYTE, INC.		9
REMEGEN CO., LTD.		16
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.	-	-
Average		16
Weighted average by Cap.		17

×